Skip to main content
. Author manuscript; available in PMC: 2020 Jan 1.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2018 Oct 23;28(1):59–66. doi: 10.1158/1055-9965.EPI-17-0945

Table 1:

Descriptive Statistics by Race-Ethnicity

Total White Black Hispanic
Variable N 989 397 411 181 p valuec

Stage at diagnosis (N=857)ae         0.003
    0 200 (23%) 93 (27%) 81 (23%) 26 (16%)
    1 289 (34%) 131 (38%) 109 (31%) 49 (30%)
    2 255 (30%) 89 (26%) 108 (31%) 58 (36%)
    3 97 (11%) 28 (8%) 46 (13%) 23 (14%)
    4 16 (2%) 2 (1%) 9 (3%) 5 (3%)
−0.28
Concentrated disadvantaged −0.00 (3.02) −2.13 (1.34) 2.18 (3.05) −0.28 (1.99) <0.001
MUA statuse         <.001
    Non-eligible 487 (49%) 281 (71%) 125 (30%) 81 (45%)
    Designated MUA 399 (40%) 114 (29%) 189 (46%) 96 (53%)
    Eligible non-designated 103 (10%) 2 (1%) 97 (24%) 4 (2%)
Drive time to mammography (mins) N=887ad 17.6 (12.7) 17.2 (13.8) 18.34(12.1) 16.6 (11.0) 0.253
Age (years)d 56.0 (11.3) 55.9 (11.2) 56.9 (11.2) 54.3 (11.6) 0.043
Education (years)d 13.1 (3.1) 14.6 (2.4) 12.9 (2.2) 10.4 (4.0) <0.001
Family income (000’s) N=952)ad 60.6 (58.0) 93.0 (66.3) 39.5 (39.5) 38.9 (39.2) <0.001
Regular Drb 854 (86%) 354 (89%) 355 (86%) 145 (80%) 0.013
Comorbidities (number)d 0.71 (1.03) 0.52 (0.89) 0.90 (1.09) 0.69 (1.09) <0.001
Insurance coveragee         <.001
    Private 524 (53%) 282 (71%) 166 (40%) 76 (42%)
    Medicare 205 (21%) 83 (21%) 94 (23%) 28 (15%)
    Medicaid 140 (14%) 13 (3%) 94 (23%) 33 (18%)
    None 120 (12%) 19 (5%) 57 (14%) 44 (24%)
Mammogram within past two yearsb 630 (64%) 259 (65%) 261 (64%) 110 (61%) 0.585
Disprortionate share facilityb 279 (28%) 42 (11%) 152 (37%) 85 (47%) <0.001
BICOE accredited facilityb 600 (61%) 321 (81%) 190 (46%) 89 (49%) <0.001
Visited more than one facility for dxb 335 (34%) 103 (26%) 147 (36%) 85 (47%) <0.001
Dx delayed more than 60 days (N=856)ab 199 (22%) 45 (12%) 100 (27%) 54 (32%) <0.001
Radiological dxb 507 (51%) 236 (59%) 195 (47%) 76 (42%) <0.001
a

Reduced N due to missing data

b

Dichotomous variable (N, %)

c

Chi-square tests on categorical variables, ANOVA on continuous

d

Continuous variable (Mean, SD)

e

Categorical variable (N, %)

HHS Vulnerability Disclosure